Thats why its essential to review how your current plans premium is changing and explore whether another option might offer better value for you and your family
Clinically Superior Results
Moreover, there can be no assurance that another company also holding orphan drug designation for the same indication, or which may receive orphan drug designation in the future will not receive approval prior to us, in which case our competitor would have the benefit of the seven years of market exclusivity, and we would be unable to commercialize our product for the same indication until the expiration of such seven-year period
Gastrointestinal adverse effects represent the most common tolerability challenges with semaglutide, affecting approximately 4050% of patients according to FDA prescribing information
It is not medical advice and should not be used as a substitute for professional evaluation, diagnosis, or treatment from a qualified healthcare provider
Retrieved from Asbaghi, O., Ghanbari, N., Shekari, M., et al